Iwilfin (DFMO) Maintenance treatment for High Risk Neuroblastoma ~ May 22nd, 2025Social Media Coordinator9 minutes ago1 min readJoin us at Joe's On Newbury on May 22nd at 6:30pm for a great review of Iwilfin for High Risk NeuroblastomaRegister
CAR-Therapy Adverse Reaction Identification and Management Considerations ~ Thursday, June 12th @ Davio's
NEW EVENT: Exploring the Role of NUBEQA (darolutamide) in mHSPC in Combination with Docetaxel and in nmCRPC PP-NUM-US-3389-1
Comments